30
Participants
Start Date
July 31, 2009
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
mifepristone
Mifepristone 300 mg to 1200 mg once daily
Sinai Hospital of Baltimore, Baltimore
The Center for Diabetes and Endocrine Care, Hollywood
University of Alabama at Birmingham School of Medicine, Birmingham
University of Mississippi Medical Center, Jackson
Cleveland Clinic Foundation; Dept of Endocrinology, Diabetes & Metabolism, Cleveland
University of Michigan Medical Center, Ann Arbor
Endocrinology Center at Community Medical Commons, Menomonee Falls
Northwestern University Feinberg Medical; Division of Endocrinology, Metabolism & Molecular Medicine, Chicago
Oklahoma Diabetes Center, Oklahoma City
University of New Mexico, Albuquerque
AMCR Institute Inc., Escondido
Oregon Health Sciences University, Portland
Stanford University Medical Center, Stanford
Massachusetts General Hospital, Boston
University of Texas Southwestern Medical Center, Dallas
Lead Sponsor
Corcept Therapeutics
INDUSTRY